Aldeyra Therapeutics signs new lease for Concord, Massachusetts headquarters
The company will relocate its corporate headquarters to a roughly 4,067-square-foot office under a lease running through September 2029.
Aldeyra Therapeutics, Inc. entered into a lease agreement on July 28, 2026 with Bradford Street, L.L.C., according to an 8-K filed with the SEC. The agreement covers approximately 4,067 square feet of office space at 23 Bradford Street, Concord, Massachusetts.1
The lease term begins September 1, 2026 and runs until September 30, 2029.1 Aldeyra plans to use the space as its corporate headquarters.1
Under the terms disclosed, Aldeyra will pay a monthly base rent of $12,201.00, with scheduled annual increases specified in the lease.1 Beyond that base rent, the company is also responsible for operating expenses, taxes, and other fees as set out in the lease.1 The lease includes standard provisions covering occupancy, maintenance, and upkeep of the premises.1 Aldeyra will also provide an initial security deposit of $50,000.00.1
The filing notes that its summary of the lease is not exhaustive and directs readers to the full agreement, which is attached as Exhibit 10.1 to the Form 8-K. The report was signed by Todd C. Brady, M.D., Ph.D., Aldeyra's Chief Executive Officer, and dated July 30, 2026.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.